Cardiovascular risk factors in patients with type 2 diabetes -: Do we follow the guidelines?

被引:30
作者
del Cañizo-Gómez, FJ
Moreira-Andrés, MN
机构
[1] Hosp Virgen Torre, Endocrinol Unit, Madrid, Spain
[2] Hosp Univ 12 Octubre, Dept Endocrinol, Madrid 28041, Spain
关键词
type 2 diabetes mellitus; cardiovascular risk factors; coronary artery disease; hypertension; dyslipidaemia;
D O I
10.1016/j.diabres.2003.12.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To assess the degree of control of modifiable cardiovascular risk factors (CRFs) in type 2 diabetic patients. Study design and methods: Cross-sectional study in 501 patients with type 2 diabetes mellitus. The following parameters were used to define optimal control: glycated haemoglobin (HbA(1c)) <7.0%, fasting plasma glucose (FPG) <7.2 mmol/l, postprandial capillary glucose (PCG) <10.0mmol/l, high-density lipoprotein cholesterol (HDL-C) >1,1 mmol/l, low-density lipoprotein cholesterol (LDL-C) <2.6 mmol/l, triglyceride levels (TG) < 1.7 mmol/l, systolic blood pressure (SBP) < 130 mmHg, diastolic blood pressure (DBP) <80 mmHg, body mass index (BMI) <25kg/m(2), waist circumference (WC) <88cm in women and < 102 cm in men, and current non-smoking status. The use of various cardioprotective medications was also evaluated. Results: Mean ( +/-S.D.) age was 65.4 +/- 11.9 years, 218 (44%) were male. Ninety-six (19%) met coronary artery disease (CAD). Two hundred seven patients (41%) had an HbA(1c) <7.0%, 134 (27%) a FPG <7.2 mmol/l and 231 of 353 (65%) a PCG < 10.0 mmol/l. Only 206 (41%) achieved an LDL-C <2.6 mmol/l, but 370 (74%) and 308 (62%) reached an HDL-C > 1.1 mmol/l and a TG levels < 1.7 mmol/l, respectively. In 359 (72%) patients DBP was < 80 mmHg, but in only 136 (27%) was SBP < 130 mm-Hg. Sixty four (13%) achieved a BMI <25 kg/m(2), and 420 (84%) were non-smokers. Forty three (15%) women and 104 (48%) men had a WC <88 or <102 cm, respectively. None of the patients had optimal control of all CRFs. Conclusions: These data demonstrate poor control of modifiable CRFs in the population studied, and support the need for great effort to achieve the recommended goals. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:125 / 133
页数:9
相关论文
共 35 条
[21]   Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes [J].
Lewis, EJ ;
Hunsicker, LG ;
Clarke, WR ;
Berl, T ;
Pohl, MA ;
Lewis, JB ;
Ritz, E ;
Atkins, RC ;
Rohde, R ;
Raz, I .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :851-860
[22]   Selection of anthropometric indicators for classification of abdominal fatness - a critical review [J].
Molarius, A ;
Seidell, JC .
INTERNATIONAL JOURNAL OF OBESITY, 1998, 22 (08) :719-727
[23]   WAIST CIRCUMFERENCE AND ABDOMINAL SAGITTAL DIAMETER - BEST SIMPLE ANTHROPOMETRIC INDEXES OF ABDOMINAL VISCERAL ADIPOSE-TISSUE ACCUMULATION AND RELATED CARDIOVASCULAR RISK IN MEN AND WOMEN [J].
POULIOT, MC ;
DESPRES, JP ;
LEMIEUX, S ;
MOORJANI, S ;
BOUCHARD, C ;
TREMBLAY, A ;
NADEAU, A ;
LUPIEN, PJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1994, 73 (07) :460-468
[24]   Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease - A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) [J].
Pyorala, K ;
Pedersen, TR ;
Kjekshus, J ;
Faergeman, O ;
Olsson, AG ;
Thorgeirsson, G .
DIABETES CARE, 1997, 20 (04) :614-620
[25]   Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol [J].
Rubins, HB ;
Robins, SJ ;
Collins, D ;
Fye, CL ;
Anderson, JW ;
Elam, MB ;
Faas, FH ;
Linares, E ;
Schaefer, EJ ;
Schectman, G ;
Wilt, TJ ;
Wittes, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (06) :410-418
[26]   Age and the burden of death attributable to diabetes in the United States [J].
Saydah, SH ;
Eberhardt, MS ;
Loria, CM ;
Brancati, FL .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 156 (08) :714-719
[27]   Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality [J].
Shaw, JE ;
Hodge, AM ;
de Courten, M ;
Chitson, P ;
Zimmet, PZ .
DIABETOLOGIA, 1999, 42 (09) :1050-1054
[28]   Impact of diabetes duration and cardiovascular risk factors on mortality in type 2 diabetes: the Hoorn Study [J].
Spijkerman, AMW ;
Dekker, JM ;
Nijpels, G ;
Jager, A ;
Kostense, PJ ;
van Hinsbergh, VWM ;
Bouter, LM ;
Heine, RJ ;
Stehouwer, CDA .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2002, 32 (12) :924-930
[29]   DIABETES, OTHER RISK-FACTORS, AND 12-YR CARDIOVASCULAR MORTALITY FOR MEN SCREENED IN THE MULTIPLE RISK FACTOR INTERVENTION TRIAL [J].
STAMLER, J ;
VACCARO, O ;
NEATON, JD ;
WENTWORTH, D .
DIABETES CARE, 1993, 16 (02) :434-444
[30]  
Stearne MR, 1998, BRIT MED J, V317, P713